SNDX
Syndax Pharmaceuticals Inc
Company overview
- Market capitalization
- $1.59B
- Employees
- 298
- Latest publication
- 2026-09-29
About Syndax Pharmaceuticals Inc
Syndax Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidate includes Revuforj (revumenib), a menin inhibitor for the treatment of relapsed or refractory R/R acute leukemia; and Niktimvo (axatilimab-csfr), a colony stimulating factor-1 receptor blocking antibody to treat chronic graft-versus-host disease. The company is also developing revumenib for the treatment of R/R acute myeloid leukemia (AML) with a nucleophosmin 1 mutation (mNPM1) and in combination with standard-of-care agents in mNPM1 AML or KMT2Ar acute leukemia, as well as for metastatic colorectal cancer; axatilimab to treat idiopathic pulmonary fibrosis; and Entinostat, a Class 1 HDAC inhibitor. It has an agreement with Eddingpharm International Company Limited for licensing, development, and commercialization of Entinostat. Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in New York, New York.
Financial statements
Income Quarterly
| Metric | Q4 20252025-12-31 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD | Q3 20232023-09-30 · USD | Q2 20232023-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 68,481,000USD | 20,042,000USD | 7,680,000USD | 12,500,000USD | 3,500,000USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | -1,572,000USD | 885,000USD | 826,000USD | 2,000USD | 44,337,000USD | 3,000USD | 3,000USD | 152,000USD |
| Gross Profit | 70,053,000USD | 19,157,000USD | 7,680,000USD | 12,500,000USD | 3,500,000USD | -3,000USD | -3,000USD | -152,000USD |
| Research Development | 78,641,000USD | 61,636,000USD | 65,529,000USD | 70,971,000USD | 48,655,000USD | 56,492,000USD | 39,087,000USD | 34,764,000USD |
| Selling General Administrative | 49,929,000USD | 41,031,000USD | 37,690,000USD | 31,106,000USD | 29,061,000USD | 23,022,000USD | 17,268,000USD | 14,914,000USD |
| Unclassified Operating Expenses | 4,031,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 132,601,000USD | 102,914,000USD | 104,045,000USD | 102,077,000USD | 77,716,000USD | 79,514,000USD | 56,355,000USD | 49,678,000USD |
| Operating Income | -62,548,000USD | -83,757,000USD | -96,365,000USD | -89,577,000USD | -74,216,000USD | -79,514,000USD | -56,355,000USD | -49,678,000USD |
| Interest Income | 4,328,000USD | 7,183,000USD | 7,108,000USD | 5,442,000USD | 6,284,000USD | 7,256,000USD | 5,345,000USD | 5,191,000USD |
| Interest Expense | 52,702,000USD | 8,051,000USD | 4,806,000USD | 23,000USD | 45,000USD | 55,000USD | 70,000USD | 35,000USD |
| Net Interest Income | -5,265,000USD | -868,000USD | 2,302,000USD | 5,419,000USD | 6,239,000USD | 7,201,000USD | 5,275,000USD | 5,156,000USD |
| Income Before Tax | -68,014,000USD | -84,846,000USD | -94,169,000USD | -84,126,000USD | -68,063,000USD | -72,400,000USD | -51,146,000USD | -44,615,000USD |
| Net Income | -68,014,000USD | -84,846,000USD | -94,169,000USD | -84,126,000USD | -68,063,000USD | -72,400,000USD | -51,146,000USD | -44,615,000USD |
| Net Income From Continuing Ops | -68,014,000USD | -84,846,000USD | -94,169,000USD | -84,126,000USD | -68,063,000USD | -72,400,000USD | -51,146,000USD | -44,615,000USD |
| Ebit | -15,312,000USD | -92,895,000USD | -96,365,000USD | -84,103,000USD | -68,018,000USD | -72,345,000USD | -51,076,000USD | -44,580,000USD |
| Ebitda | -15,309,000USD | -83,757,000USD | -89,363,000USD | -84,101,000USD | -68,015,000USD | -72,342,000USD | -51,073,000USD | -44,577,000USD |
| Depreciation And Amortization | 3,000USD | 9,138,000USD | 7,002,000USD | 2,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD |
| Reconciled Depreciation | 3,000USD | 0USD | 0USD | 2,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD |
| Total Other Income Expense Net | -5,466,000USD | -1,089,000USD | 2,196,000USD | 5,451,000USD | 6,153,000USD | 7,114,000USD | 5,209,000USD | 5,063,000USD |
| Income Tax Expense | — | — | — | -2,000USD | — | -40,276USD | -3,000USD | -58,000USD |
| Non Operating Income Net Other | — | — | — | — | — | — | — | 5,098,000USD |
| Net Income Applicable To Common Shares | — | — | — | — | — | — | — | -44,615,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20172017-12-31 · USD | FY 20162016-12-31 · USD | FY 20112011-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 126,576,000USD | 139,709,000USD | 1,517,000USD | 1,517,000USD | 2,108,000USD | 1,220,000USD | — |
| Cost Of Revenue | 12,000USD | 454,000USD | 456,000USD | — | — | 63,986,000USD | 41,697,000USD | 51,000USD |
| Gross Profit | -12,000USD | -454,000USD | 139,709,000USD | 1,517,000USD | 1,517,000USD | 2,108,000USD | 1,220,000USD | -51,000USD |
| Research Development | 163,032,000USD | 118,499,000USD | 88,248,000USD | 50,435,000USD | 42,994,000USD | 48,201,000USD | 31,665,000USD | 6,087,000USD |
| Selling General Administrative | 66,922,000USD | 33,258,000USD | 25,241,000USD | 22,505,000USD | 16,062,000USD | 15,861,000USD | 13,321,000USD | — |
| Total Operating Expenses | 229,954,000USD | 151,757,000USD | 113,489,000USD | 72,940,000USD | 59,056,000USD | 64,062,000USD | 44,986,000USD | 9,572,000USD |
| Operating Income | -229,954,000USD | -151,757,000USD | 26,220,000USD | -71,423,000USD | -57,539,000USD | -61,954,000USD | -43,766,000USD | -9,623,000USD |
| Interest Income | 18,601,000USD | 5,872,000USD | 403,000USD | 841,000USD | 1,571,000USD | 1,421,000USD | 956,000USD | — |
| Interest Expense | 208,000USD | 3,137,000USD | 1,899,000USD | 2,357,000USD | 1,571,000USD | 1,421,000USD | 956,000USD | 1,986,000USD |
| Net Interest Income | 18,413,000USD | 2,735,000USD | -1,496,000USD | -1,516,000USD | 1,571,000USD | 1,421,000USD | 956,000USD | — |
| Income Before Tax | -209,360,000USD | -149,338,000USD | 24,926,000USD | -73,158,000USD | -56,047,000USD | -60,802,000USD | -44,472,000USD | -13,089,000USD |
| Net Income | -209,360,000USD | -143,749,000USD | 24,926,000USD | -73,069,000USD | -55,955,000USD | -60,802,000USD | -44,472,000USD | -13,089,000USD |
| Net Income From Continuing Ops | -176,081,000USD | -149,338,000USD | 24,926,000USD | -73,158,000USD | -56,047,000USD | -60,802,000USD | -44,472,000USD | — |
| Ebit | -209,152,000USD | -151,757,000USD | 26,220,000USD | -71,423,000USD | -57,539,000USD | -61,954,000USD | -43,766,000USD | -11,103,000USD |
| Ebitda | -209,140,000USD | -151,724,000USD | 26,263,000USD | -71,334,000USD | -57,447,000USD | -61,878,000USD | -43,677,000USD | -11,052,000USD |
| Depreciation And Amortization | 12,000USD | 33,000USD | 43,000USD | 89,000USD | 92,000USD | 76,000USD | 89,000USD | 51,000USD |
| Reconciled Depreciation | 12,000USD | 33,000USD | 43,000USD | 89,000USD | 92,000USD | 76,000USD | — | — |
| Total Other Income Expense Net | 20,594,000USD | 2,419,000USD | -1,294,000USD | -1,735,000USD | 1,492,000USD | 1,152,000USD | -706,000USD | -3,466,000USD |
| Income Tax Expense | — | -5,589,000USD | -43,000USD | -89,000USD | -92,000USD | -76,000USD | -89,000USD | — |
| Net Income Applicable To Common Shares | — | -149,338,000USD | 24,926,000USD | -77,064,000USD | -56,047,000USD | -60,802,000USD | -47,070,000USD | — |
| Non Operating Income Net Other | — | — | 605,000USD | 622,000USD | -79,000USD | -269,000USD | -1,662,000USD | — |
| Unclassified Operating Expenses | — | — | — | — | — | — | — | 3,485,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 703,652,000USD | 472,668,000USD | 529,706,000USD | 551,792,000USD | 596,149,000USD | 640,707,000USD | 724,816,000USD | 425,811,000USD |
| Cash And Equivalents | 336,477,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 547,860,000USD | 352,064,000USD | 394,070,000USD | 454,174,000USD | 468,706,000USD | 516,313,000USD | 582,913,000USD | 389,607,000USD |
| Short Term Investments | 211,383,000USD | 221,171,000USD | 259,140,000USD | 337,366,000USD | 360,070,000USD | 362,320,000USD | 428,830,000USD | 256,588,000USD |
| Long Term Investments | 27,217,000USD | — | 0USD | 20,146,000USD | 62,627,000USD | 89,938,000USD | 119,520,000USD | 10,029,000USD |
| Total Current Assets | 675,039,000USD | 471,177,000USD | 528,081,000USD | 529,830,000USD | 531,676,000USD | 548,751,000USD | 603,057,000USD | 414,809,000USD |
| Other Current Assets | 17,480,000USD | 23,472,000USD | 63,261,000USD | 7,591,000USD | 7,850,000USD | 6,292,000USD | 5,907,000USD | 20,512,000USD |
| Total Liabilities | 688,553,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 99,677,000USD | 86,174,000USD | 120,116,000USD | 114,187,000USD | 112,987,000USD | 94,551,000USD | 103,549,000USD | 59,377,000USD |
| Total Stockholder Equity | 15,099,000USD | 41,622,000USD | 64,630,000USD | 115,430,000USD | 157,424,000USD | 215,059,000USD | 288,124,000USD | 366,432,000USD |
| Total Equity Including Noncontrolling Interest | 15,099,000USD | — | — | — | — | — | — | — |
| Net Receivables | 45,067,000USD | 60,693,000USD | 37,996,000USD | 43,065,000USD | 37,424,000USD | 21,482,000USD | 13,871,000USD | 4,690,000USD |
| Inventory | 33,164,000USD | 34,948,000USD | 32,754,000USD | 25,000,000USD | 17,696,000USD | 4,664,000USD | 366,000USD | -4,690,000USD |
| Property Plant Equipment Net | 1,294,000USD | 1,389,000USD | 1,523,000USD | 1,599,000USD | 1,629,000USD | 1,801,000USD | 2,022,000USD | 756,000USD |
| Accounts Payable | 4,874,000USD | 10,843,000USD | 16,580,000USD | 13,826,000USD | 17,353,000USD | 10,047,000USD | 11,626,000USD | 4,898,000USD |
| Short Term Debt | 506,000USD | 488,000USD | 472,000USD | 23,256,000USD | 350,000USD | 384,000USD | 12,596,000USD | 852,000USD |
| Common Stock | 9,000USD | 9,000USD | 9,000USD | 9,000USD | 9,000USD | 9,000USD | 9,000USD | 9,000USD |
| Retained Earnings | -1,598,616,000USD | -1,549,253,000USD | -1,506,580,000USD | -1,438,566,000USD | -1,377,851,000USD | -1,306,004,000USD | -1,221,158,000USD | -1,126,989,000USD |
| Total Liab | — | 431,046,000USD | 465,076,000USD | 436,362,000USD | 438,725,000USD | 425,648,000USD | 436,692,000USD | 59,379,000USD |
| Other Current Liab | — | 74,843,000USD | 103,064,000USD | 77,105,000USD | 95,284,000USD | 84,120,000USD | 79,327,000USD | 53,627,000USD |
| Capital Stock | — | 9,000USD | 9,000USD | 9,000USD | 9,000USD | 9,000USD | 9,000USD | 9,000USD |
| Cash | — | 130,893,000USD | 134,930,000USD | 116,808,000USD | 108,636,000USD | 153,993,000USD | 154,083,000USD | 133,019,000USD |
| Net Debt | — | 214,467,000USD | 211,553,000USD | 228,623,000USD | -106,961,000USD | -152,156,000USD | 191,656,000USD | -132,165,000USD |
| Short Long Term Debt Total | — | 345,360,000USD | 346,483,000USD | 345,431,000USD | 1,675,000USD | 1,837,000USD | 345,739,000USD | 854,000USD |
| Long Term Debt | — | 343,965,000USD | 343,909,000USD | — | — | — | 331,565,000USD | — |
| Property Plant Equipment Gross | — | 1,818,000USD | 1,948,000USD | 1,599,000USD | 1,629,000USD | 1,801,000USD | 2,441,000USD | 756,000USD |
| Accumulated Other Comprehensive Income | — | 11,000USD | 452,000USD | 525,000USD | 285,000USD | 527,000USD | 163,000USD | 371,000USD |
| Common Stock Shares Outstanding | — | 86,620,992shares | 86,620,992shares | 86,620,992shares | 86,337,237shares | 85,622,000shares | 85,791,198shares | 85,433,569shares |
| Non Current Assets Total | — | 1,491,000USD | 1,625,000USD | 21,962,000USD | 64,473,000USD | 91,956,000USD | 121,759,000USD | 11,002,000USD |
| Non Current Liabilities Total | — | 344,872,000USD | 344,960,000USD | 322,175,000USD | 325,738,000USD | 331,097,000USD | 333,143,000USD | 2,000USD |
| Non Currrent Assets Other | — | 102,000USD | 102,000USD | 217,000USD | 217,000USD | 217,000USD | 217,000USD | 217,000USD |
| Net Working Capital | — | 385,003,000USD | 407,965,000USD | 415,643,000USD | 418,689,000USD | 454,200,000USD | 499,508,000USD | 355,432,000USD |
| Unclassified Equity | — | 1,590,846,000USD | 1,570,740,000USD | 1,553,453,000USD | 1,534,972,000USD | 1,520,518,000USD | 1,509,101,000USD | 1,493,032,000USD |
| Non Current Liabilities Other | — | — | — | 320,985,000USD | 324,413,000USD | 329,644,000USD | — | — |
| Short Long Term Debt | — | — | — | — | — | — | 12,116,000USD | — |
| Unclassified Current Liabilities | — | — | — | — | — | — | -12,116,000USD | — |
| Current Deferred Revenue | — | — | — | — | — | — | — | -852,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 529,706,000USD | 724,816,000USD | 612,880,000USD | 497,236,000USD | 449,657,000USD | 300,613,000USD | 63,525,000USD | 83,938,000USD |
| Other Current Assets | 11,350,000USD | 5,907,000USD | 2,066,000USD | 1,332,000USD | 1,137,000USD | 5,624,000USD | 2,440,000USD | 2,081,000USD |
| Total Liab | 465,076,000USD | 436,692,000USD | 58,684,000USD | 29,787,000USD | 41,289,000USD | 48,425,000USD | 31,925,000USD | 30,891,000USD |
| Total Stockholder Equity | 64,630,000USD | 288,124,000USD | 554,196,000USD | 467,449,000USD | 408,368,000USD | 252,188,000USD | 31,600,000USD | 53,047,000USD |
| Other Current Liab | 103,064,000USD | 79,327,000USD | 47,088,000USD | 24,276,000USD | 14,652,000USD | 11,246,000USD | 10,195,000USD | 13,149,000USD |
| Common Stock | 9,000USD | 9,000USD | 8,000USD | 7,000USD | 6,000USD | 5,000USD | 3,000USD | 2,000USD |
| Capital Stock | 9,000USD | 9,000USD | 8,000USD | 7,000USD | 6,000USD | 5,000USD | 3,000USD | 2,000USD |
| Retained Earnings | -1,506,580,000USD | -1,221,158,000USD | -902,400,000USD | -693,040,000USD | -543,702,000USD | -568,628,000USD | -495,470,000USD | -439,423,000USD |
| Cash | 134,930,000USD | 154,083,000USD | 295,394,000USD | 74,356,000USD | 221,965,000USD | 115,243,000USD | 24,609,000USD | 33,769,000USD |
| Cash And Short Term Investments | 413,686,000USD | 582,913,000USD | 577,583,000USD | 484,397,000USD | 446,830,000USD | 293,065,000USD | 59,775,000USD | 80,911,000USD |
| Total Current Assets | 528,081,000USD | 603,057,000USD | 580,876,000USD | 489,786,000USD | 448,396,000USD | 298,864,000USD | 62,331,000USD | 83,346,000USD |
| Total Current Liabilities | 120,116,000USD | 103,549,000USD | 58,096,000USD | 29,065,000USD | 20,683,000USD | 18,872,000USD | 18,368,000USD | 16,105,000USD |
| Net Debt | 211,553,000USD | 191,656,000USD | -293,759,000USD | -73,195,000USD | -200,997,000USD | -94,707,000USD | -23,712,000USD | -33,769,000USD |
| Short Term Debt | 472,000USD | 12,596,000USD | 1,047,000USD | 439,000USD | 362,000USD | 2,601,000USD | 478,000USD | 13,014,000USD |
| Short Long Term Debt Total | 346,483,000USD | 345,739,000USD | 1,635,000USD | 1,161,000USD | 20,968,000USD | 20,536,000USD | 897,000USD | — |
| Long Term Debt | 343,909,000USD | 331,565,000USD | — | — | 19,894,664USD | 17,834,000USD | — | — |
| Long Term Investments | 0USD | 119,520,000USD | 29,829,000USD | 5,469,000USD | 0USD | — | — | 0USD |
| Short Term Investments | 278,756,000USD | 428,830,000USD | 282,189,000USD | 410,041,000USD | 224,865,000USD | 177,822,000USD | 35,166,000USD | 47,142,000USD |
| Net Receivables | 70,291,000USD | 13,871,000USD | 1,227,000USD | 4,057,000USD | 429,000USD | 175,000USD | 116,000USD | 253,000USD |
| Inventory | 32,754,000USD | 366,000USD | 2,003,000USD | -4,251,000USD | 7,651,000USD | 5,283,000USD | 1,677,000USD | 1,053,000USD |
| Accounts Payable | 16,580,000USD | 11,626,000USD | 9,961,000USD | 4,350,000USD | 5,669,000USD | 3,508,000USD | 6,178,000USD | 1,439,000USD |
| Property Plant Equipment Net | 1,523,000USD | 2,022,000USD | 1,495,000USD | 1,059,000USD | 1,261,000USD | 482,000USD | 997,000USD | 373,000USD |
| Property Plant Equipment Gross | 1,948,000USD | 2,441,000USD | 1,906,000USD | 1,458,000USD | 1,704,000USD | 482,000USD | 997,000USD | 373,000USD |
| Accumulated Other Comprehensive Income | 452,000USD | 163,000USD | 218,000USD | -806,000USD | 45,000USD | -4,000USD | -310,000USD | -25,000USD |
| Common Stock Shares Outstanding | 86,625,610shares | 85,622,000shares | 70,370,519shares | 60,760,906shares | 52,064,809shares | 41,308,242shares | 30,490,783shares | 25,371,511shares |
| Non Current Assets Total | 1,625,000USD | 121,759,000USD | 32,004,000USD | 7,450,000USD | 1,261,000USD | 1,749,000USD | 1,194,000USD | 592,000USD |
| Non Current Liabilities Total | 344,960,000USD | 333,143,000USD | 588,000USD | 722,000USD | 20,606,000USD | 29,553,000USD | 13,557,000USD | 14,786,000USD |
| Non Currrent Assets Other | 102,000USD | 217,000USD | 680,000USD | 922,000USD | 983,000USD | 1,267,000USD | 82,000USD | 219,000USD |
| Net Working Capital | 407,965,000USD | 499,508,000USD | 522,780,000USD | 460,721,000USD | 427,713,000USD | 279,992,000USD | 43,963,000USD | 67,241,000USD |
| Unclassified Equity | 1,570,740,000USD | 1,509,101,000USD | 1,456,362,000USD | 1,161,281,000USD | 952,013,000USD | 820,810,000USD | 527,374,000USD | 492,491,000USD |
| Short Long Term Debt | — | 12,116,000USD | — | — | — | 2,285,000USD | — | — |
| Unclassified Current Liabilities | — | -12,116,000USD | -38,968,000USD | — | -12,764,000USD | -2,285,000USD | — | -13,014,000USD |
| Current Deferred Revenue | — | — | 38,968,000USD | — | 12,764,000USD | 1,517,000USD | 1,517,000USD | 1,517,000USD |
| Other Assets | — | — | — | 922,000USD | 0USD | 1,557,000USD | 0USD | 219,000USD |
| Net Tangible Assets | — | — | — | 467,449,000USD | 408,368,000USD | 252,188,000USD | 31,600,000USD | 53,047,000USD |
| Non Current Liabilities Other | — | — | — | — | 711,000USD | 11,719,000USD | 5,000USD | 136,000USD |
| Unclassified Current Assets | — | — | — | — | -7,651,000USD | -5,283,000USD | -1,677,000USD | — |
| Other Liab | — | — | — | — | — | 11,618,000USD | 13,138,000USD | 14,786,000USD |
| Unclassified Non Current Assets | — | — | — | — | — | -1,557,000USD | — | — |
| Unclassified Non Current Liabilities | — | — | — | — | — | -11,618,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -42,673,000USD | -68,014,000USD | -60,715,000USD | -71,847,000USD | -84,846,000USD | -94,169,000USD | -84,126,000USD | -68,063,000USD |
| Depreciation | 4,000USD | 3,000USD | -164,000USD | 55,000USD | 112,000USD | 0USD | 2,000USD | 3,000USD |
| Stock Based Compensation | 12,054,000USD | 11,254,000USD | 12,082,000USD | 13,787,000USD | 10,380,000USD | 12,297,000USD | 11,934,000USD | 9,896,000USD |
| Other Non Cash Items | -676,000USD | -973,000USD | 1,641,000USD | -3,039,000USD | -3,266,000USD | -2,702,000USD | -2,763,000USD | -3,407,000USD |
| Change To Account Receivables | 6,017,000USD | -18,997,000USD | -5,987,000USD | -3,771,000USD | -8,075,000USD | -6,004,000USD | 4,349,000USD | -3,509,000USD |
| Change To Inventory | -2,060,000USD | -7,801,000USD | -7,183,000USD | -12,916,000USD | -4,191,000USD | — | — | 0USD |
| Change In Working Capital | -19,054,000USD | -11,758,000USD | -23,379,000USD | -26,751,000USD | -17,430,000USD | 27,186,000USD | 12,631,000USD | -10,074,000USD |
| Total Cash From Operating Activities | -50,345,000USD | -69,488,000USD | -70,535,000USD | -87,795,000USD | -95,162,000USD | -57,388,000USD | -62,322,000USD | -71,645,000USD |
| Capital Expenditures | 0USD | -56,000USD | -131,000USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -50,345,000USD | -69,544,000USD | -70,666,000USD | -87,795,000USD | -95,162,000USD | -57,388,000USD | -62,322,000USD | -71,645,000USD |
| Investments | 38,390,000USD | 81,634,000USD | 72,429,000USD | 41,887,000USD | 94,142,000USD | -268,973,000USD | 86,847,000USD | 61,750,000USD |
| Total Cashflows From Investing Activities | 38,390,000USD | 81,578,000USD | 72,429,000USD | 41,887,000USD | 94,142,000USD | -268,973,000USD | 86,847,000USD | 61,750,000USD |
| Total Cash From Financing Activities | 7,918,000USD | 5,917,000USD | 6,278,000USD | 551,000USD | 930,000USD | 347,425,000USD | 3,098,000USD | 676,000USD |
| Change In Cash | -4,037,000USD | 18,007,000USD | 8,172,000USD | -45,357,000USD | -90,000USD | 21,064,000USD | 27,623,000USD | -9,219,000USD |
| Begin Period Cash Flow | 135,032,000USD | 117,025,000USD | 108,853,000USD | 154,210,000USD | 154,300,000USD | 133,236,000USD | 105,613,000USD | 114,832,000USD |
| End Period Cash Flow | 130,995,000USD | 135,032,000USD | 117,025,000USD | 108,853,000USD | 154,210,000USD | 154,300,000USD | 133,236,000USD | 105,613,000USD |
| Other Cashflows From Financing Activities | 7,918,000USD | 5,917,000USD | 6,278,000USD | 551,000USD | 930,000USD | 347,425,000USD | 3,098,000USD | 676,000USD |
| Other Cashflows From Investing Activities | — | — | — | — | — | — | — | 61,750,000USD |
| Unclassified Investing Cash Flow | — | — | — | — | — | — | — | -61,750,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -285,422,000USD | -318,758,000USD | -209,360,000USD | 24,926,000USD | -73,158,000USD | -56,047,000USD | -73,961,000USD | -60,802,000USD |
| Depreciation | 6,000USD | 8,000USD | 12,000USD | 43,000USD | 89,000USD | 92,000USD | 78,000USD | 76,000USD |
| Stock Based Compensation | 47,503,000USD | 43,026,000USD | 30,951,000USD | 13,317,000USD | 9,057,000USD | 6,005,000USD | 6,201,000USD | 5,450,000USD |
| Other Non Cash Items | -5,749,000USD | -12,449,000USD | -14,064,000USD | 187,000USD | 686,000USD | 359,000USD | 11,000USD | 8,000USD |
| Change To Account Receivables | -36,830,000USD | -11,237,000USD | 10,706,000USD | — | — | — | — | — |
| Change To Inventory | -32,091,000USD | -366,000USD | -10,706,000USD | — | — | — | — | — |
| Change In Working Capital | -79,318,000USD | 13,270,000USD | 31,860,000USD | -9,597,000USD | -7,934,000USD | -241,000USD | -302,000USD | 7,674,000USD |
| Total Cash From Operating Activities | -322,980,000USD | -274,903,000USD | -160,601,000USD | 29,131,000USD | -71,260,000USD | -50,612,000USD | -68,531,000USD | -47,371,000USD |
| Capital Expenditures | -187,000USD | 0USD | 0USD | -129,000USD | -129,000USD | -129,000USD | -187,000USD | -84,000USD |
| Free Cash Flow | -323,167,000USD | -274,903,000USD | -160,601,000USD | 29,002,000USD | -71,260,000USD | -50,612,000USD | -68,718,000USD | -47,455,000USD |
| Investments | 290,223,000USD | -219,775,000USD | -3,730,000USD | -40,744,000USD | -142,530,000USD | 12,781,000USD | 51,585,000USD | -17,027,000USD |
| Total Cashflows From Investing Activities | 290,036,000USD | -219,775,000USD | 117,609,000USD | -40,873,000USD | -142,530,000USD | 12,781,000USD | 51,398,000USD | -17,027,000USD |
| Total Cash From Financing Activities | 13,676,000USD | 353,367,000USD | 264,132,000USD | 118,464,000USD | 304,424,000USD | 28,570,000USD | 15,729,000USD | 75,722,000USD |
| Issuance Of Capital Stock | 0USD | 0USD | 162,364,000USD | 86,337,000USD | 277,715,000USD | 28,210,000USD | 15,497,000USD | — |
| Change In Cash | -19,268,000USD | -141,311,000USD | 221,140,000USD | 106,722,000USD | 90,634,000USD | -9,261,000USD | -1,404,000USD | 11,324,000USD |
| Begin Period Cash Flow | 154,300,000USD | 295,611,000USD | 74,471,000USD | 115,358,000USD | 24,724,000USD | 33,985,000USD | 35,389,000USD | 23,844,000USD |
| End Period Cash Flow | 135,032,000USD | 154,300,000USD | 295,611,000USD | 222,080,000USD | 115,358,000USD | 24,724,000USD | 33,985,000USD | 35,168,000USD |
| Other Cashflows From Financing Activities | 13,676,000USD | 343,652,000USD | 6,038,000USD | 32,127,000USD | 6,634,000USD | 360,000USD | 232,000USD | 374,000USD |
| Net Borrowings | — | 0USD | 0USD | -20,996,000USD | 19,730,000USD | 19,730,000USD | 19,730,000USD | 19,730,000USD |
| Unclassified Financing Cash Flow | — | 9,715,000USD | 95,730,000USD | 82,485,000USD | -6,633,000USD | -20,090,000USD | -19,954,000USD | 28,571,000USD |
| Unclassified Investing Cash Flow | — | — | 121,339,000USD | — | — | — | — | — |
| Change To Liabilities | — | — | — | 4,930,000USD | -2,103,000USD | 1,328,000USD | 182,000USD | 2,698,000USD |
| Sale Purchase Of Stock | — | — | — | 24,848,000USD | 284,693,000USD | 28,570,000USD | 15,721,000USD | 27,047,000USD |
| Cash And Cash Equivalents Changes | — | — | — | 106,722,000USD | 90,634,000USD | -9,261,000USD | -1,404,000USD | 11,324,000USD |
| Other Cashflows From Investing Activities | — | — | — | -40,744USD | -142,530USD | 12,781USD | 51,585USD | 45,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Product | Collaboration Revenue | 18,088,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Product | 54,700,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Product | Collaboration Revenue | 15,941,000 | USD | 0001193125-26-197154 |
| Q1 2026Quarterly · 2026-03-31 | Product | Product | 48,923,000 | USD | 0001193125-26-197154 |
| FY 2025Yearly · 2025-12-31 | Product | Collaboration Revenue | 42,367,000 | USD | 0001193125-26-076536 |
| FY 2025Yearly · 2025-12-31 | Product | Milestone Revenue | 5,141,000 | USD | 0001193125-26-076536 |
| FY 2025Yearly · 2025-12-31 | Product | Net Product Revenues | 124,844,000 | USD | 0001193125-26-076536 |
| Q3 2025Quarterly · 2025-09-30 | Product | Collaboration Revenue | 13,864,000 | USD | 0001193125-25-262521 |
| Q3 2025Quarterly · 2025-09-30 | Product | Milestone Revenue | 0 | USD | 0001193125-25-262521 |
| Q3 2025Quarterly · 2025-09-30 | Product | Product | 32,007,000 | USD | 0001193125-25-262521 |
| Q2 2025Quarterly · 2025-06-30 | Product | Collaboration Revenue | 9,358,000 | USD | 0000950170-25-101985 |
| Q2 2025Quarterly · 2025-06-30 | Product | Milestone Revenue | 0 | USD | 0000950170-25-101985 |
| Q2 2025Quarterly · 2025-06-30 | Product | Product | 28,600,000 | USD | 0000950170-25-101985 |
| Q1 2025Quarterly · 2025-03-31 | Product | Collaboration Revenue | 0 | USD | 0001193125-26-197154 |
| Q1 2025Quarterly · 2025-03-31 | Product | Product | 20,042,000 | USD | 0001193125-26-197154 |
| FY 2024Yearly · 2024-12-31 | Product | Collaboration Revenue | 0 | USD | 0001193125-26-076536 |
| FY 2024Yearly · 2024-12-31 | Product | Milestone Revenue | 16,000,000 | USD | 0001193125-26-076536 |
| FY 2024Yearly · 2024-12-31 | Product | Net Product Revenues | 7,680,000 | USD | 0001193125-26-076536 |
| Q3 2024Quarterly · 2024-09-30 | Product | Collaboration Revenue | 0 | USD | 0001193125-25-262521 |
| Q3 2024Quarterly · 2024-09-30 | Product | Milestone Revenue | 12,500,000 | USD | 0001193125-25-262521 |
| Q3 2024Quarterly · 2024-09-30 | Product | Product | 0 | USD | 0001193125-25-262521 |
| Q2 2024Quarterly · 2024-06-30 | Product | Collaboration Revenue | 0 | USD | 0000950170-25-101985 |
| Q2 2024Quarterly · 2024-06-30 | Product | Milestone Revenue | 3,500,000 | USD | 0000950170-25-101985 |
| Q2 2024Quarterly · 2024-06-30 | Product | Product | 0 | USD | 0000950170-25-101985 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.